placebo control study
Recently Published Documents


TOTAL DOCUMENTS

48
(FIVE YEARS 9)

H-INDEX

9
(FIVE YEARS 1)

Author(s):  
Fathima Nafha Nizamdeen ◽  
Mohd Aleemuddin Quamri ◽  
Md Anzar Alam

Abstract Objectives Diabetic peripheral neuropathy (DPN) is a common diabetes complication. The prevalence of neuropathy is 55% for type 1 and 66% for type 2 diabetes. In Unani medicine neuropathy is known as Khidr (numbness). It is treated with drugs possessing hypoglycemic and analgesic properties, etc. Habb-e-Asab, a polyherbal Unani formulation used for the treatment of Waja-ul-Asab (neuralgia) is routinely used for its indications in neurological pain in Unani medicine. The aim of this study to investigate the efficacy of Habb-e-Asab in diabetic peripheral neuropathy. Methods Thirty patients with DPN were randomly assigned to test (n=20) and control (n=10) groups in a randomized single-blind placebo control study. For 45 days, the test group was given 250 mg Habb-e-Asab twice a day and the control group 250 mg placebo twice a day. The subjective parameters Pain in feet, burning in feet, and tingling in feet was assessed by the arbitrary scale and VAS fortnightly and objective parameters MNSI, and VPT was assessed in pre–post-treatment. Results The research drug revealed highly statistically significant with p<0.001 on VAS score and MNSI whereas VPT is significant with p<0.01 on few points. But control group exhibits no significant effect in any of the parameters. No adverse effects had been reported in either group. Conclusions Our finding indicated that the Habb-e-Asab for 45 days improved and reduced the severity of DPN in a patient with diabetes (CTRI/2018/02/011725).


CNS Spectrums ◽  
2021 ◽  
pp. 1-30
Author(s):  
Yoshiteru Takekita ◽  
Shuichi Hiraoka ◽  
Yasuhiro Iwama ◽  
Naotaka Sunada ◽  
Nobuatsu Aoki ◽  
...  

2018 ◽  
Vol 29 ◽  
pp. 75-75
Author(s):  
Bruna Sinjari ◽  
Gianmaria D'Addazio ◽  
Tonino Traini ◽  
Giovanna Murmura ◽  
Sergio Caputi

Sign in / Sign up

Export Citation Format

Share Document